Literature DB >> 11185416

Antibiotic resistance among enterococcal strains isolated from clinical specimens.

Z Barisić1, V Punda-Polić.   

Abstract

The distribution and resistance patterns of clinical isolates of enterococci from hospital patients were compared with those obtained from outpatients. Of 235 enterococcal isolates 212 (90.2%) were identified as Enterococcus faecalis and 23 (9.8%) as E. faecium. E. faecium occurred more frequently in specimens from hospitalized patients than from outpatients (P < 0.001). Over 90% of all E. faecalis isolates were susceptible to ampicillin. Resistance to ampicillin occurred in 66.7% of hospital strains of E. faecium. High-level resistance to gentamicin (MIC > 500 mg/l) was seen in 37.03% of inpatients' and in 11.5% of outpatients' E. faecalis isolates and in 76.2% of hospital isolates of E. faecium. High-level streptomycin resistance (MIC > 2000 mg/l) occurred in 52.8% of E. faecalis and 76.2% of E. faecium hospital isolates. There were no isolates resistant to vancomycin. The community acquired strains isolated from outpatients were more susceptible than isolates from hospitalized patients to all antimicrobial agents tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11185416     DOI: 10.1016/s0924-8579(00)00197-7

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  2 in total

1.  Isolation and identification of enterococci from seawater samples: assessment of their resistance to antibiotics and heavy metals.

Authors:  Ayten Kimiran-Erdem; Elif Ozlem Arslan; Nazmiye Ozlem Sanli Yurudu; Zuhal Zeybek; Nihal Dogruoz; Aysin Cotuk
Journal:  Environ Monit Assess       Date:  2006-12-14       Impact factor: 2.513

2.  Occurrence of aminoglycoside-modifying-enzyme genes aac(6')-aph(2"), aph(3'), ant(4') and ant(6) in clinical isolates of Enterococcus faecalis resistant to high-level of gentamicin and amikacin.

Authors:  M Filipová; H Bujdákova; H Drahovská; A Lisková; J Hanzen
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.